CN101843699B - Chinese medicament for treating benign prostatic hyperplasiabrain - Google Patents
Chinese medicament for treating benign prostatic hyperplasiabrain Download PDFInfo
- Publication number
- CN101843699B CN101843699B CN2009102354921A CN200910235492A CN101843699B CN 101843699 B CN101843699 B CN 101843699B CN 2009102354921 A CN2009102354921 A CN 2009102354921A CN 200910235492 A CN200910235492 A CN 200910235492A CN 101843699 B CN101843699 B CN 101843699B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- chinese
- chinese medicament
- radix
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating benign prostatic hyperplasiabrain, and belongs to the field of Chinese medicaments for treating urinary system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: Indian buead, lucid ganoderma, root of rehmannia, plantain seed, radix pseudo-ginseng, Chinese angelica and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, and clearing heat and promoting urination, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment diseases of urinary system.
Background technology
The present Chinese medicine aspect that is used for the treatment of male prostatic hyperplasia, the deficiency that has two aspects: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of prostatic hyperplasia patients are because of can not get the treatment of active drug for a long time, frequent frequent micturition, urgent micturition, dysurea, urine retention, protracted course of disease, symptoms such as very misery, and Chang Bingfa cystitis, hematuria.Patient and family members thereof are very dissatisfied.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of prostatic hyperplasia, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, and the slower problem that takes effect is effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of prostatic hyperplasia adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Poria 4-30 part Ganoderma 2-15 part Radix Rehmanniae 4-30 part
Semen Plantaginis 3-20 part Radix Notoginseng 3-20 part Radix Angelicae Sinensis 4-30 part
The Chinese medicine of this treatment prostatic hyperplasia is made by following method:
(1) by above-mentioned weight ratio, Poria, the Radix Rehmanniae, Semen Plantaginis, Radix Angelicae Sinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with the extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae benefiting QI and nourishing blood in the side, the body resistance strengthening and constitution consolidating, tonification the five internal organs; Radix Angelicae Sinensis, Radix Notoginseng nourshing blood and promoting blood circulation, blood-activating analgetic; The Poria promoting diuresis to eliminate damp pathogen is usually used in treating the edema oliguria; The Semen Plantaginis clearing away heat and promoting diuresis, eliminating dampness by diuresis is treating stranguria, and it is not smooth to be apt to control dribbling urination, Urethra astringent pain.All medicine compatibilities bring out the best in each other, and have the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of clearing away heat and promoting diuresis, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Poria 80 kairine sesames 40 gram Radix Rehmanniae 80 grams
Semen Plantaginis 60 gram Radix Notoginseng 60 gram Radix Angelicae Sinensis 80 grams
Weight in accordance with regulations, with conventional water extraction process Poria, the Radix Rehmanniae, Semen Plantaginis, Radix Angelicae Sinensis are extracted, make extractum fine powder 90 grams, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with the extractum fine powder, make fine particle, adorn capsule No. 0, make 678 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Poria 160 kairine sesames 70 gram Radix Rehmanniae 160 grams
Semen Plantaginis 100 gram Radix Notoginseng 100 gram Radix Angelicae Sinensis 160 grams
By above-mentioned same method, make 1228 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Poria 300 kairine sesames 150 gram Radix Rehmanniae 300 grams
Semen Plantaginis 200 gram Radix Notoginseng 200 gram Radix Angelicae Sinensis 300 grams
By above-mentioned same method, make 2428 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
6 parts in 3 parts of Radix Rehmanniae of 6 portions of Ganodermas of Poria
6 parts of 4 parts of Radix Angelicae Sinensis of 5 portions of Radix Notoginseng of Semen Plantaginis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
20 parts in 10 parts of Radix Rehmanniae of 20 portions of Ganodermas of Poria
20 parts of 16 parts of Radix Angelicae Sinensis of 16 portions of Radix Notoginseng of Semen Plantaginis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is example with the prostatic hyperplasia, through 8 routine clinical observations.Selecting the tcm diagnosis prostatic hyperplasia is standard: male's limb is soft weak, physical weakness, and it is not smooth to urinate---frequent micturition, urgent micturition, dysurea, urine retention, urine retention.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, be the male all, there is not other serious disease, the age is 49 years old-82 years old, 65.7 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are obviously alleviated; Urine retention, urine retention alleviate.
2, effective: body constitution strengthens, on one's body energetically; Frequent micturition, urgent micturition, dysurea are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 2 times, each 5 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 3 months after, symptom is obviously improved.8 philtrums of clinical experiment, produce effects 4 people, effective 3 people, invalid 1 people, total effective rate 87.5%.
Claims (1)
1. a Chinese medicine for the treatment of prostatic hyperplasia is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Poria 4---30 parts of 30 portions of Ganodermas 2---15 parts of Radix Rehmanniae 4---
Semen Plantaginis 3---30 parts of 20 portions of Radix Notoginseng 3---20 parts of Radix Angelicae Sinensis 4---;
The Chinese medicine of this treatment prostatic hyperplasia is made by following method:
(1) by above-mentioned weight ratio, Poria, the Radix Rehmanniae, Semen Plantaginis, Radix Angelicae Sinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with the extractum fine powder; As required, make Chinese medicine granules, powder, capsule, watered pill, Tabules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354921A CN101843699B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating benign prostatic hyperplasiabrain |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354921A CN101843699B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating benign prostatic hyperplasiabrain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843699A CN101843699A (en) | 2010-09-29 |
| CN101843699B true CN101843699B (en) | 2011-08-17 |
Family
ID=42768635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102354921A Expired - Fee Related CN101843699B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating benign prostatic hyperplasiabrain |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843699B (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102068594A (en) * | 2010-09-16 | 2011-05-25 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating chronic prostatitis |
| CN101953920A (en) * | 2010-10-14 | 2011-01-26 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating prostatic hyperplasia |
| CN101972345A (en) * | 2010-10-14 | 2011-02-16 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic prostatitis |
| CN101972426A (en) * | 2010-10-21 | 2011-02-16 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic prostatitis |
| CN101961407A (en) * | 2010-10-27 | 2011-02-02 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating prostatic hyperplasia |
| CN101961416A (en) * | 2010-10-27 | 2011-02-02 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic prostatitis |
| CN101979004A (en) * | 2010-11-04 | 2011-02-23 | 北京绿源求证科技发展有限责任公司 | Chinese medicament for treating benign prostatic hyperplasia |
| CN101966257A (en) * | 2010-11-04 | 2011-02-09 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic prostatitis |
| CN101991681A (en) * | 2010-11-11 | 2011-03-30 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
| CN102139009A (en) * | 2010-11-18 | 2011-08-03 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic prostatitis |
| CN102138992A (en) * | 2010-11-18 | 2011-08-03 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating benign prostatic hyperplasia |
| CN102091157A (en) * | 2010-11-25 | 2011-06-15 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating hyperplasia of prostate |
| CN102114122A (en) * | 2010-12-13 | 2011-07-06 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating chronic prostatitis |
| CN102114172A (en) * | 2010-12-24 | 2011-07-06 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating hyperplasia of prostate |
| CN103223052B (en) * | 2013-04-27 | 2015-05-27 | 陈晖� | Traditional Chinese medicine used for treating prostatitis |
-
2009
- 2009-10-16 CN CN2009102354921A patent/CN101843699B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843699A (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843699B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843789B (en) | Chinese medicament for treating gout | |
| CN101843804A (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101850071B (en) | Chinese medicament for treating chronic nephritis | |
| CN101850020B (en) | Chinese medicament for treating chronic kidney failure | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843803A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN101843698B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843867B (en) | Chinese medicament for treating gout | |
| CN101843706B (en) | Chinese medicament for treating chronic kidney failure | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101884747B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN101843693A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN102018760A (en) | Traditional Chinese medicine for treating benign prostatic hyperplasia | |
| CN101843750B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843697B (en) | Chinese medicament for treating chronic kidney failure | |
| CN101843816B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843695B (en) | Chinese medicament for treating chronic kidney failure | |
| CN101843818B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843833B (en) | Chinese medicament for treating diabetic nephropathy | |
| CN101843777B (en) | Chinese medicament for treating liver cirrhosis | |
| CN101843767A (en) | Chinese medicament for treating chronic kidney failure | |
| CN102018856A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN101843866A (en) | Chinese medicament for treating diabetic feet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO JUNZHANG ELECTRONICS CO., LTD. Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130809 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130809 Address after: Zhu Yao Cun Bai Pu Zhen 226500 Jiangsu city of Rugao Province in 18 groups Patentee after: Rugao Jun Zhang Electronics Co., Ltd. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110817 Termination date: 20171016 |